Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A cataract that has material basis in heterozygous mutation in the VIM gene on chromosome 10p13.
Features include always present findings: Pulverulent cataract, Posterior polar cataract, and Diffuse nuclear cataract.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 3 | Pulverulent cataract, Posterior polar cataract, Diffuse nuclear cataract |
VIM function has not been fully characterized.
Cataract 30 is associated with mutations in the VIM gene on chromosome 10.
Genetic testing for VIM is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for cataract 30 has been reported in the published literature.
Phenotype severity distribution: 3 always present features.
No clinical trials have been registered for cataract 30.
203 publications have been identified in PubMed for cataract 30. Kisho has analyzed 114 by research type. Research spans Epidemiology / Natural History (36%), Clinical Trial Publication (23%), and Review / Meta-Analysis (17%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 41 | 36% |
Data assembled from 5 of 12 sources · Last updated Sep 18, 2026, 1:42 AM UTC
Online Mendelian Inheritance in Man
Clinical study results
26 |
23% |
Research summaries | 19 | 17% |
Laboratory research | 14 | 12% |
Testing and diagnosis research | 9 | 8% |
Patient case studies | 3 | 3% |
New treatment approaches | 2 | 2% |
Huang AY (2026). [PMID: 41714392](https://pubmed.ncbi.nlm.nih.gov/41714392/). *Eye (Lond)*. [Clinical Trial Publication]
McCormick I (2026). [PMID: 41687671](https://pubmed.ncbi.nlm.nih.gov/41687671/). *Lancet Glob Health*. [Basic Science / Preclinical]
Cassano F (2026). [PMID: 41615444](https://pubmed.ncbi.nlm.nih.gov/41615444/). *Graefes Arch Clin Exp Ophthalmol*. [Review / Meta-Analysis]
John PR (2026). [PMID: 41586508](https://pubmed.ncbi.nlm.nih.gov/41586508/). *Anesthesiology*. [Review / Meta-Analysis]
Kaur K (2026). [PMID: 35201717](https://pubmed.ncbi.nlm.nih.gov/35201717/). *Unknown Journal*. [Basic Science / Preclinical]
Öcal O (2026). [PMID: 41761679](https://pubmed.ncbi.nlm.nih.gov/41761679/). *Pediatr Transplant*. [Epidemiology / Natural History]
Oral M (2026). [PMID: 42142872](https://pubmed.ncbi.nlm.nih.gov/42142872/). *J AAPOS*. [Diagnostic / Biomarker]
Folk GA (2026). [PMID: 41251071](https://pubmed.ncbi.nlm.nih.gov/41251071/). *Curr Opin Ophthalmol*. [Review / Meta-Analysis]
Yang J (2026). [PMID: 41796175](https://pubmed.ncbi.nlm.nih.gov/41796175/). *Sci Rep*. [Diagnostic / Biomarker]
Jiang X (2026). [PMID: 40825656](https://pubmed.ncbi.nlm.nih.gov/40825656/). *Br J Ophthalmol*. [Epidemiology / Natural History]